OSSIFI
OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and accelerate return to function. Unlike orthobiologic competitors, OssiFi utilizes a proprietary small molecule to modulate bone growth through Sclerostin inhibition. Its carrier matrix is intended to combine excellent handling characteristics, ideal release kinetics and cellular in-growth capabilities with demonstrated biocompatibility. The company plans to conduct rigorous scientific and clinical studies to prove superior efficacy and safety over standard of care. This evidence, which is lacking in competitive biomaterials, will ultimately drive their commercial success and support the best patient care possible.
OSSIFI
Industry:
Health Care Medical Medical Device
Founded:
2011-01-01
Address:
Kansas City, Missouri, United States
Country:
United States
Website Url:
http://www.ossifi.com
Total Employee:
11+
Status:
Active
Contact:
(913)945-6763
Total Funding:
1.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Nginx Amazon Google Apps For Business GoDaddy DNS
Similar Organizations
Accure Acne
Accure is a medical device company committed to developing a novel and impactful solution for acne sufferers.
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.ossifi.com Semrush global rank: 5.29 M Semrush visits lastest month: 1.56 K
- Host name: staticip.multiscreensite.com
- IP address: 35.172.94.1
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "OssiFi"
OssiFi
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation. ABOUT US. OssiFi Therapeutics is an innovative bone-biology company operating at the intersection of therapeutics …See details»
OssiFi - Crunchbase Company Profile & Funding
OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and …See details»
OssiFi - LinkedIn
OssiFi Therapeutics is developing market disruptive anti-sclerostin regenerative bone-biology products to address significant unmet needs in low back pain, fracture repair, and fracture prevention.See details»
OssiFi Company Profile | Management and Employees List
OssiFi Profile and History . OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and …See details»
OssiFi - Contacts, Employees, Board Members, Advisors & Alumni
OssiFi is a medical tech company that focuses on developing bone graft substitutes to stimulate fracture repair.See details»
OSSIFI INC. Company Profile | Overland Park, KS | Competitors ...
Find company research, competitor information, contact details & financial data for OSSIFI INC. of Overland Park, KS. Get the latest business insights from Dun & Bradstreet.See details»
Our Team - OssiFi
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation. ABOUT US. OssiFi Therapeutics is an innovative bone-biology …See details»
OssiFi - Products, Competitors, Financials, Employees, …
OssiFi is a bone-biology company that develops therapeutics and medical devices in the healthcare sector. The company is involved in creating sclerostin small molecule inhibitors for …See details»
Partnerships - OssiFi
When you partner with OssiFi, you gain significant experience, dedication and commitment from a biopharmaceutical organization focused on developing meaningful treatments to allow patients …See details»
OssiFi Therapeutics 2025 Company Profile: Valuation, Funding ...
OssiFi Therapeutics General Information Description. Developer of graft substitutes designed to stimulate bone density and reduce the rate of resorption. The company develops multiple …See details»
OssiFi - Crunchbase
OssiFi is a medical tech company that focuses on developing bone graft substitutes to stimulate fracture repair.See details»
Contact Us / Map - OssiFi
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation. ABOUT US. OssiFi Therapeutics is an innovative bone-biology …See details»
OssiFi Inc | VentureRadar
OssiFi’s proprietary development approach lends itself to a safe therapeutic - with less human adverse effects in clinical trials. OssiFi’s therapeutics outperform the current standard of care …See details»
OssiFi - Funding, Financials, Valuation & Investors - Crunchbase
OssiFi is a medical tech company that focuses on developing bone graft substitutes to stimulate fracture repair. ... Pricing. Log In. Log In. Experience the new Crunchbase, powered by AI . …See details»
OssiFi - Overview, News & Similar companies | ZoomInfo.com
Unlike orthobiologic competitors, OssiFi utilizes a proprietary small molecule to modulate bone growth through Sclerostin inhibition. Its carrier matrix is intended to combine excellent handling …See details»
OssiFi Inc - VentureRadar
OssiFi’s proprietary development approach lends itself to a safe therapeutic - with less human adverse effects in clinical trials. OssiFi’s therapeutics outperform the current standard of care …See details»
Introducing UniFi Organizations – Ubiquiti Help Center
To get started, see Creating a UniFi Organization for a complete setup guide. Key Features Centralized Identity & Access Management (IAM) Unified list of users and admins across all …See details»
Products - OssiFi
OssiFi combines the novelty of its targets and therapeutic approach with well-established technologies to rapidly and efficiently bring product candidates into clinical development. …See details»
Investor Relations - OssiFi
OssiFi is a “qualified company” under the Kansas Angel Tax Credit program and therefore investors are eligible to receive a 50% Kansas tax credit up to a maximum of $100,000 per …See details»
Our Advisors - ossifi.com
OssiFi takes pride in finding the perfect match for our team. We have created a culture that resonates our innovation. ABOUT US. OssiFi Therapeutics is an innovative bone-biology …See details»